Avion Wealth’s Intellia Therapeutics NTLA Stock Holding History

Avion Wealth’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	149	–	–	﹤0.01%	1099
2026 Q1	$1K	Hold	149	–	–	﹤0.01%	1095
2025 Q4	$1K	Hold	149	–	–	﹤0.01%	1087
2025 Q3	$2K	Hold	149	–	–	﹤0.01%	885
2025 Q2	$1K	Buy	149 +107	+255%	+$879	﹤0.01%	1022
2025 Q1	$0	Buy	+42	New	+$424	﹤0.01%	1255
2024 Q4	–	Sell	-23	Closed	–	–	1197
2024 Q3	$0	Buy	23 +4	+21%	+$92	﹤0.01%	1234
2024 Q2	$0	Buy	+19	New	+$452	﹤0.01%	1158
2023 Q4	–	Sell	-13	Closed	–	–	1258
2023 Q3	$0	Buy	+13	New	+$504	﹤0.01%	1077

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Avion Wealth's NTLA Position: Q2 2026 in Review

Avion Wealth held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 149 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Avion Wealth first reported a position in NTLA in Q3 2023 and has held it in 9 quarters since. 329 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

Avion Wealth held 149 shares of Intellia Therapeutics worth $2K as of Q2 2026.
Avion Wealth left its Intellia Therapeutics share count unchanged in Q2 2026.
Intellia Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1099 holding.
Avion Wealth first reported a position in Intellia Therapeutics in Q3 2023 and has held it in 9 quarters since.
329 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.